You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1431 Developing an FDA-qualified drug development tool, the membrane proteome array, for specificity testing of antibodies and CAR-T cell therapies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Regulatory, Financial and Access Considerations
1431 Developing an FDA-qualified drug development tool, the membrane proteome array, for specificity testing of antibodies and CAR-T cell therapies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202310608
Dec 20233805
Jan 20243303
Feb 20241803
Mar 20244602
Apr 20242402
May 20243400
Jun 20241200
Jul 20243803
Aug 20243201
Sep 20243802
Oct 20244605
Nov 20245805
Dec 20244608
Jan 20252206
Feb 2025404
Mar 2025007
Apr 2025007
May 2025008
Jun 2025003
Total595082